Investors
Measured fitness, outside the lab.
VenTracer is a wireless VO2max breath analyzer in development by Caropet Technologies Pvt. Ltd. (Rapid Circuitry), Hyderabad, India. We are open to conversations with investors who know hardware, sports science or longevity health.
In short
VenTracer for investors, in three answers.
What problem does VenTracer solve?
VO2max and ventilatory thresholds are measured from breath gas exchange, which today means a lab metabolic cart. Most people instead get a heart-rate estimate from a watch, which validation studies find is often 5 to 10% off. VenTracer is being built to make the measurement wireless, on the mask, wherever people train.
Who pays first?
Sports-science labs and longevity clinics, which already run VO2max and threshold tests and want them outside the lab, in the sport, with raw breath-by-breath data. They are being recruited now as pilot and validation partners. Coaches and serious athletes follow.
Why this team?
VenTracer is designed and engineered in-house by Rapid Circuitry in Hyderabad: an electronics design group of about 25 engineers across embedded systems, PCB design, firmware, IoT and software, with 500+ delivered projects including medical, industrial, automotive and consumer products.
Where we are
Stage and next milestones.
- Stage
- Concept and system architecture
- Next
- Engineering prototypes, planned for
- Then
- Side-by-side validation against a lab metabolic cart, results published first
- First customers
- Sports-science labs and longevity clinics, via the pilot programme
- Company
- Caropet Technologies Pvt. Ltd. (Rapid Circuitry), Hyderabad, India
- Founder
- Aditya Chilka, Founder and CEO
Why it matters beyond sport: in a study of 122,007 patients, low cardiorespiratory fitness was linked to higher long-term mortality, comparably to smoking or diabetes (Mandsager et al., 2018). That is why longevity clinics track fitness, and why measuring it well matters. More in our guides: VO2max and longevity and the portable analyzer landscape.
Questions
What investors ask first.
Is VenTracer raising money?
VenTracer is open to conversations with investors. There is no public offer on this page; email aditya@rapidcircuitry.com to start a conversation.
Does VenTracer have a product yet?
Not yet. VenTracer is at the concept and architecture stage, with engineering prototypes planned for 2027, followed by validation against a laboratory metabolic cart and pilot units for labs and clinics.
Who builds VenTracer?
VenTracer is designed and engineered in-house by Rapid Circuitry, the electronics design brand of Caropet Technologies Pvt. Ltd. in Hyderabad, India, led by founder and CEO Aditya Chilka. Rapid Circuitry has delivered 500+ projects across medical, industrial, automotive and consumer products.
Who are the first customers?
Sports-science labs and longevity clinics come first: they already run VO2max and threshold tests and are being recruited as pilot and validation partners. Coaches and serious athletes follow.
Has VenTracer published accuracy data?
No. VenTracer will be tested side by side with a laboratory metabolic cart, and the results published before any accuracy claim is made.
This page is for information only and is not an offer or solicitation to buy or sell any securities.
Start a conversation.
Email the founder directly. We reply within five working days.